Laura Sanz Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

3/2002

Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Sanz Research Topics

Disease

43	Neoplasms (Cancer) 01/2024 - 05/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2013
4	Malaria 01/2018 - 07/2004
3	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2022
3	Fibrosarcoma 01/2011 - 05/2005
2	Multiple Myeloma 02/2024 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2005
2	Inflammation (Inflammations) 05/2016 - 05/2015
2	Communicable Diseases (Infectious Diseases) 05/2015 - 08/2013
1	Neutropenia 05/2024
1	Thrombocytopenia (Thrombopenia) 05/2024
1	COVID-19 12/2023
1	Virus Diseases (Viral Diseases) 12/2023
1	Obesity 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Leukemia 01/2022
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017
1	Cytokine Release Syndrome 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 08/2013
1	Substance-Related Disorders (Drug Abuse) 08/2013
1	Alzheimer Disease (Alzheimer's Disease) 08/2013
1	Carcinoma (Carcinomatosis) 01/2009
1	Melanoma (Melanoma, Malignant) 01/2007
1	Experimental Melanoma 07/2005
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2002

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 05/2024 - 02/2004
12	AntigensIBA 01/2023 - 02/2004
8	Monoclonal AntibodiesIBA 01/2023 - 12/2005
7	Bispecific AntibodiesIBA 01/2022 - 01/2014
3	Immunoglobulin G (IgG)IBA 05/2024 - 07/2005
3	Immunotoxins (Immunotoxin)IBA 01/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
3	Immunoglobulin FragmentsIBA 01/2009 - 10/2003
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 09/2009
2	blinatumomabIBA 01/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 05/2015
2	Collagen Type XVIII (Type XVIII Collagen)IBA 11/2018 - 07/2006
2	Single-Chain AntibodiesIBA 11/2018 - 01/2017
2	Single-Domain AntibodiesIBA 11/2018 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 05/2015 - 08/2013
2	CollagenIBA 03/2012 - 01/2009
2	Carcinoembryonic AntigenIBA 09/2009 - 01/2009
2	Peptide Hydrolases (Proteases)FDA Link 07/2006 - 06/2003
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024
1	Trinitrotoluene (TNT)IBA 12/2023
1	Neutralizing AntibodiesIBA 12/2023
1	Natural Killer Cell ReceptorsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	AlbuminsIBA 09/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Insulin-Like Growth Factor Binding Protein 3IBA 10/2020
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Muromonab-CD3 (Muromonab CD3)FDA Link 01/2017
1	artemisinin (artemisinine)IBA 01/2017
1	NucleotidesIBA 05/2016
1	SJ733IBA 12/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2013
1	Retinaldehyde (Retinal)IBA 08/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Formaldehyde (Formol)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	ParaffinIBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	matrigelIBA 01/2011
1	Surface Antigens (Surface Antigen)IBA 09/2009
1	Laminin (Merosin)IBA 01/2009
1	EpitopesIBA 01/2009
1	ChemokinesIBA 01/2007
1	Chemokine CCL21IBA 01/2007
1	Angiogenesis InhibitorsIBA 07/2006
1	EndostatinsIBA 07/2006
1	Cancer VaccinesIBA 04/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	Complementary DNA (cDNA)IBA 07/2005
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2005
1	Fc Receptors (Fc Receptor)IBA 07/2005
1	Immunoglobulin Fc FragmentsIBA 07/2005
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2005
1	Norgestrienone (A 301)IBA 05/2005
1	FurinIBA 05/2005
1	IntegrinsIBA 06/2003
1	Integrin alpha4beta1 (VLA-4)IBA 03/2002
1	Fibronectins (Fibronectin)IBA 03/2002
1	fludarabineIBA 03/2002

Therapy/Procedure

21	Therapeutics 01/2023 - 05/2002
13	Immunotherapy 01/2024 - 03/2009
1	Microspheres (Microsphere) 01/2018
1	Drug Therapy (Chemotherapy) 01/2013